Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1651 of 5804
-
Can scans tell who needs surgery after liver tumor shrinks?
Knowledge-focused OngoingThe goal of this observational study is to learn about the long-term treatment outcomes for patients with initially unresectable hepatocellular carcinoma (HCC) who achieve successful downstaging with the combination therapy of TACE, lenvatinib, and a PD-1 inhibitor. The main ques…
Sponsor: First Affiliated Hospital, Sun Yat-Sen University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Reading the genetic code to understand differences in sex development
Knowledge-focused ENROLLING_BY_INVITATIONThis study seeks to identify genetic causes of conditions that affect the gonads and genitals, and to study the impact on families of receiving genetic results.
Phase: NA • Sponsor: Boston Children's Hospital • Aim: Knowledge-focused
Last updated Jul 24, 2026 00:00 UTC
-
Second chance: precise radiation aims to tame recurrent prostate cancer
Disease control Recruiting nowA dose-response relationship for radiation in the management of prostate cancer is well established. Local recurrence of prostate cancer after external beam radiotherapy occurs in at least 40% of patients treated because of inability to deliver sufficient dose through external be…
Phase: NA • Sponsor: British Columbia Cancer Agency • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Womb surgery aims to save babies' kidneys and lungs
Disease control Recruiting nowThe purpose of the study is to study the outcomes of maternal and fetal patients who are undergoing fetal intervention for severe isolated lower urinary tract obstruction (LUTO).
Phase: NA • Sponsor: Rodrigo Ruano • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
New hope for schizophrenia patients who Can't take antipsychotics?
Symptom relief Recruiting nowPrevious studies found that some NMDA-enhancing agent was able to augment antioxidant activity and its adjunctive therapy was better than placebo in reducing clinical symptoms and cognitive deficits and revealed favorable safety in patients with chronic schizophrenia. Of note, a …
Phase: PHASE2 • Sponsor: China Medical University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
New hope for rare bleeding disorder: Single-Dose rituximab may replace daily chemo
Disease control CompletedPurpose: To evaluate the efficacy when administering steroid combined with single dose rituximab to eliminate the antibody in acquired hemophilia A patients compared to treatment using steroid with cyclophosphamide. The study will test the hypothesis that steroid combined with …
Phase: PHASE4 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New hope for tough colorectal cancer: drug combo shows promise
Disease control OngoingThis phase II clinical trial studies how well panitumumab with or without trametinib works in treating patients with stage IV colorectal cancer. Immunotherapy with monoclonal antibodies, such as panitumumab, may help the body's immune system attack the cancer, and may interfere w…
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
New pill combo shows promise for tough brain cancer
Disease control Recruiting nowThis is a multi-center, open-label study to evaluate the safety, pharmacokinetics (PK), and anti-cancer activity of oral administration of emavusertib alone or in combination with ibrutinib in adult participants with relapsed or refractory (R/R) hematologic malignancies. This tr…
Phase: PHASE1, PHASE2 • Sponsor: Curis, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Experimental drug tarlatamab targets tough lung cancer
Disease control OngoingA study to assess the safety, tolerability, and PK of tarlatamab in participants with SCLC
Phase: PHASE1 • Sponsor: Amgen • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Focused radiation doses put to the test for large brain tumors
Disease control OngoingThere is a lack of prospective trial data and consensus guidelines describing the use of Fractionated Stereotactic Radiation Therapy (FSRT) in the treatment of brain metastases. There has been no prospective dose escalation study performed to date to determine the maximum tolerat…
Phase: NA • Sponsor: Albert Einstein College of Medicine • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Knee surgery patients get bone marrow shot to halt arthritis
Disease control OngoingThe proposed research study aims to evaluate the effects of autologous bone marrow aspirate concentrate (BMAC) on the development and progression of osteoarthritis (OA) in patients undergoing meniscectomy. This prospective, randomized, double-blind clinical trial will compare pat…
Phase: NA • Sponsor: Rush University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Immune booster and radiation combo tested before breast cancer surgery
Disease control OngoingThis study is being done to assess the feasibility of pembrolizumab (study drug) combined with standard radiation to the tumor (tumor boost) before patients undergo standard treatment that can consist of one or more of the following: breast-conserving surgery, radiation to the en…
Phase: PHASE1, PHASE2 • Sponsor: Stephen Shiao • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Lupus pain drug shows promise in early trial
Symptom relief CompletedThe objective of this study is to evaluate the efficacy, safety, and tolerability of JBT-101 (also known as lenabasum) in systemic lupus erythematosus (SLE). * One hundred adults with active joint disease and at least moderate pain will be enrolled in this study to evaluate trea…
Phase: PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Personalized cancer vaccine shows promise in early trial
Disease control CompletedThis is a Phase 1a/1b, open-label, multicenter, global, dose-escalation study designed to evaluate the safety, tolerability, immune response, and pharmacokinetics of autogene cevumeran (RO7198457) as a single agent and in combination with atezolizumab (MPDL3280A, an engineered an…
Phase: PHASE1 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Can a common sedative calm ICU delirium without a breathing tube?
Symptom relief CompletedThe primary purpose of the study is to evaluate whether dexmedetomidine is effective in treating agitated delirium of non-intubated ICI patients
Phase: PHASE3 • Sponsor: University Hospital, Clermont-Ferrand • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
Could a simple anesthesia change boost pancreatic cancer survival?
Disease control CompletedThe purpose of this randomized controlled trial is to investigate the effects of epidural anesthesia and analgesia on the overall survival,disease-free survival and recovery in patients undergoing pancreatic cancer surgery. This study will also evaluate the effects of this techni…
Phase: NA • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New drug troriluzole tested for OCD patients not helped by antidepressants
Symptom relief CompletedThe purpose of this study is to evaluate the efficacy of troriluzole as adjunctive therapy versus placebo in participants with obsessive compulsive disorder (OCD) who had an inadequate response to selective serotonin reuptake inhibitor (SSRI), clomipramine, venlafaxine, or desven…
Phase: PHASE2, PHASE3 • Sponsor: Biohaven Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC
-
New balloon treatment shows promise for men with enlarged prostate
Symptom relief CompletedA prospective, non-randomized study. The subjects will be enrolled and treated with the Optilume BPH Prostatic DCB Dilation Catheter System at up to 8 clinical sites. The post-treatment follow-up visit can be up to 5 years. The objective of the study is to evaluate the safety an…
Phase: PHASE2 • Sponsor: Urotronic Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC
-
Blood test could sharpen lung cancer screening, study says
Diagnosis Recruiting nowThis is a prospective observational study that will follow patients who undergo lung cancer screening at the San Francisco VA Medical Center, University of California, San Francisco (UCSF) Medical Center, and the San Francisco General Hospital. The proposed study will comprise of…
Sponsor: University of California, San Francisco • Aim: Diagnosis
Last updated Jun 27, 2026 13:02 UTC
-
New combo therapy shows promise for rare gut and lung cancers
Disease control CompletedThe purpose of this study is to: * Assess overall radiographic response rate (ORR) * Assess progression-free survival (PFS) * Test the safety and tolerability of Pembrolizumab in combination with lenvatinib
Phase: PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC